TY  - JOUR

T1  - Correction: Proliferation and AKT Activity Biomarker Analyses after Capivasertib (AZD5363) Treatment of Patients with ER+ Invasive Breast Cancer (STAKT)

JO  - Clinical Cancer Research

UR  - http://dx.doi.org/10.1158/1078-0432.ccr-22-3568

PY  - 2022/12/15

AU  - Robertson JFR

AU  - Coleman RE

AU  - Cheung K-L

AU  - Evans A

AU  - Holcombe C

AU  - Skene A

AU  - Rea D

AU  - Ahmed S

AU  - Jahan A

AU  - Horgan K

AU  - Rauchhaus P et al

ED  - 

DO  - DOI: 10.1158/1078-0432.ccr-22-3568

PB  - American Association for Cancer Research (AACR)

VL  - 28

IS  - 24

SP  - 5469

EP  - 5469

Y2  - 2025/10/10

ER  -